WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious
The Food and Drug Administration says it will remove a long-standing warning from hormone-based drugs used to treat menopause symptoms in women. The change announced Monday is a break from more than 20 years of FDA policy, in which the drugs carried the agency’s most severe warning label.
WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart
EL PASO, Texas (KVIA) -- Warning labels on estrogen used in therapy for treating symptoms of menopause has discouraged many women from using it in the past. Today the Food and Drug Administration is asking companies to remove what is known as "black box warnings" on hormone therapy drugs containing …
FDA drops decades-old boxed warning on many estrogen and progestin menopause drugs, updating labels while keeping uterine cancer guidance and prescriber information
In a pivotal move, the US Food and Drug Administration on Monday said it is taking steps to remove the lengthy “black box” warning on many hormone treatments for women with menopause symptoms — a shift expected to give women more options for treatment and generate a flood of new prescriptions.
The FDA will remove black box warnings on hormone replacement therapy products for menopause treatment. Labels previously mentioned risk of breast cancer, heart disease and dementia, but FDA officials say this info is misleading.
Hormone therapy drugs have carried box warning labels for years. Food and Drug Administration Commissioner Marty Makary talks with NPR about why the agency is removing them.
WASHINGTON (AP) — Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart
WASHINGTON -- Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced Monday.
“The FDA is initiating the removal of broad black box warnings from hormone replacement therapy products for menopause,” said Robert F. Kennedy Jr. on Monday.
Hormone replacement therapies used to treat menopause symptoms no longer need to carry strict warnings about potential side effects, including cancer and heart disease, the Food and Drug Administration announced
Showing the first 25 of 26 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
FDA lifts ‘black box’ warning labels from menopause hormone drugs | Since Then